Luca G. Wanderlingh
Publications by Year
Research Areas
Cancer, Hypoxia, and Metabolism, Cancer-related gene regulation, Epigenetics and DNA Methylation, Pluripotent Stem Cells Research, CRISPR and Genetic Engineering
Most-Cited Works
- → MiT/ TFE factors control ER ‐phagy via transcriptional regulation of FAM 134B(2020)96 cited
- → Collagen Prolyl Hydroxylation–Dependent Metabolic Perturbation Governs Epigenetic Remodeling and Mesenchymal Transition in Pluripotent and Cancer Cells(2019)56 cited
- → Repurposing of tamoxifen ameliorates CLN3 and CLN7 disease phenotype(2021)44 cited
- → Synthetic Lethality Screening Identifies FDA-Approved Drugs that Overcome ATP7B-Mediated Tolerance of Tumor Cells to Cisplatin(2020)33 cited
- → Automatic identification of small molecules that promote cell conversion and reprogramming(2021)31 cited
- → 6-Bromoindirubin-3′-oxime intercepts GSK3 signaling to promote and enhance skeletal muscle differentiation affecting miR-206 expression in mice(2019)27 cited
- → High-Throughput Screening Identifies Kinase Inhibitors That Increase Dual Adeno-Associated Viral Vector Transduction In Vitro and in Mouse Retina(2018)14 cited
- → Automatic identification of small molecules that promote cell conversion and reprogramming - plate scans, colony quantification scripts, and DECCODE ranking(2020)2 cited